Neurofibromatosis Type 1-Associated Malignant Melanoma: Molecular Evidence of Inactivation of the NF1 Gene
-
Published:2009-10-10
Issue:
Volume:
Page:300-309
-
ISSN:
-
Container-title:Methods of Cancer Diagnosis, Therapy, and Prognosis
-
language:
-
Short-container-title:
Publisher
Springer Netherlands
Reference41 articles.
1. Andersen, L.B., Fountain, J.W., Gutmann, D.H., Tarle, S.A., Glover, T.W., Dracopoli, N.C., Housman, D.E., and Collins, F.S. (1993) Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat. Genet. 3:118–121 2. Boucneau, J., De Schepper, S., Vuylsteke, M., Van Hummelen, P., Naeyaert, J.M., and Lambert, J. (2005) Gene expression profiling of cultured human NF1 heterozygous (NF1+/-) melanocytes reveals downregulation of a transcriptional cis-regulatory network mediating activation of the melanocyte-specific dopachrome tautomerase (DCT) gene. Pigment. Cell. Res. 18:285–299 3. Davies, H., Bignell, G.R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M.J., Bottomley, W., Davis, N., Dicks, E., Ewing, R., Floyd, Y., Gray, K., Hall, S., Hawes, R., Hughes, J., Kosmidou, V., Menzies, A., Mould, C., Parker, A., Stevens, C., Watt, S., Hooper, S., Wilson, R., Jayatilake, H., Gusterson, B.A., Cooper, C., Shipley, J., Hargrave, D., Pritchard-Jones, K., Maitland, N., Chenevix-Trench, G., Riggins, G.J., Bigner, D.D., Palmieri, G., Cossu, A., Flanagan, A., Nicholson, A., Ho, J.W., Leung, S.Y., Yuen, S.T., Weber, B.L., Seigler, H.F., Darrow, T.L., Paterson, H., Marais, R., Marshall, C.J., Wooster, R., Stratton, M.R., and Futreal, P.A. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954 4. de Schepper, S., Boucneau, J., Lambert, J., Messiaen, L., and Naeyaert, J.M. (2005) Pigment cell-related manifestations in neurofibromatosis type 1: an overview. Pigment. Cell. Res. 18:13–24 5. de Schepper, S., Boucneau, J., Vander Haeghen, Y., Messiaen, L., Naeyaert, J.M., and Lambert, J. (2006a) Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind? Arch. Dermatol. Res. 297:439–449
|
|